Newsroom

Press Release

NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

NeoGenomics Provides COVID-19 Business Update

NeoGenomics Integrates HALO(R) From Indica Labs

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients